Baseline characteristics of the omega‐3 fatty acids ( F ish oils) and A spirin in V ascular access OU tcomes in RE nal D isease ( FAVOURED ) study

The Fish oils and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial investigated whether 3 months of omega‐3 polyunsaturated fatty acids, either alone or in combination with aspirin, would effectively reduce primary access failure of de novo arteriovenous fistulae. This report pr...

Full description

Saved in:
Bibliographic Details
Published in:Nephrology (Carlton, Vic.) Vic.), 2016-03, Vol.21 (3), p.217-228
Main Authors: Viecelli, Andrea K, Pascoe, Elaine M, Polkinghorne, Kevan R, Hawley, Carmel M, Paul‐Brent, Peta‐Anne, Badve, Sunil V, Cass, Alan, Johnson, David W, Kerr, Peter G, Mori, Trevor A, Scaria, Anish, Hooi, Seong L, Ong, Meng L, Irish, Ashley B
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Fish oils and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial investigated whether 3 months of omega‐3 polyunsaturated fatty acids, either alone or in combination with aspirin, would effectively reduce primary access failure of de novo arteriovenous fistulae. This report presents the baseline characteristics of all study participants, and examines whether study protocol amendments successfully increased recruitment of a broader and more representative haemodialysis cohort, including patients already receiving aspirin, and compares Malaysian participants with those from Australia, New Zealand and the United Kingdom. The FAVOURED study participants were on average younger and had less ischaemic heart disease than in contemporary national registry reports, and these differences were reduced as a consequence of including patients already receiving aspirin.
ISSN:1320-5358
1440-1797
DOI:10.1111/nep.12573